These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 27826926)
1. Analysis of the Distribution Profiles of Circulating MicroRNAs by Asymmetrical Flow Field Flow Fractionation. Flack K; Jimenez LA; Zhong W Methods Mol Biol; 2017; 1509():161-168. PubMed ID: 27826926 [TBL] [Abstract][Full Text] [Related]
2. A Robust Protocol to Quantify Circulating Cancer Biomarker MicroRNAs. Bell E; Watson HL; Bailey S; Murray MJ; Coleman N Methods Mol Biol; 2017; 1580():265-279. PubMed ID: 28439839 [TBL] [Abstract][Full Text] [Related]
3. Distribution profiling of circulating microRNAs in serum. Ashby J; Flack K; Jimenez LA; Duan Y; Khatib AK; Somlo G; Wang SE; Cui X; Zhong W Anal Chem; 2014 Sep; 86(18):9343-9. PubMed ID: 25191694 [TBL] [Abstract][Full Text] [Related]
5. Multicenter Evaluation of Circulating Plasma MicroRNA Extraction Technologies for the Development of Clinically Feasible Reverse Transcription Quantitative PCR and Next-Generation Sequencing Analytical Work Flows. Kloten V; Neumann MHD; Di Pasquale F; Sprenger-Haussels M; Shaffer JM; Schlumpberger M; Herdean A; Betsou F; Ammerlaan W; Af Hällström T; Serkkola E; Forsman T; Lianidou E; Sjöback R; Kubista M; Bender S; Lampignano R; Krahn T; Schlange T; Clin Chem; 2019 Sep; 65(9):1132-1140. PubMed ID: 31235535 [TBL] [Abstract][Full Text] [Related]
6. Droplet Digital PCR for Absolute Quantification of Extracellular MicroRNAs in Plasma and Serum: Quantification of the Cancer Biomarker hsa-miR-141. Giraldez MD; Chevillet JR; Tewari M Methods Mol Biol; 2018; 1768():459-474. PubMed ID: 29717459 [TBL] [Abstract][Full Text] [Related]
7. Quantification of Circulating MicroRNAs by Droplet Digital PCR. Ferracin M; Negrini M Methods Mol Biol; 2018; 1768():445-457. PubMed ID: 29717458 [TBL] [Abstract][Full Text] [Related]
8. Comparison of commercial exosome isolation kits for circulating exosomal microRNA profiling. Ding M; Wang C; Lu X; Zhang C; Zhou Z; Chen X; Zhang CY; Zen K; Zhang C Anal Bioanal Chem; 2018 Jun; 410(16):3805-3814. PubMed ID: 29671027 [TBL] [Abstract][Full Text] [Related]
9. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer. Hasanzadeh M; Movahedi M; Rejali M; Maleki F; Moetamani-Ahmadi M; Seifi S; Hosseini Z; Khazaei M; Amerizadeh F; Ferns GA; Rezayi M; Avan A J Cell Physiol; 2019 Feb; 234(2):1289-1294. PubMed ID: 30191988 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs as biomarkers in cancer diagnosis. Sohel MMH Life Sci; 2020 May; 248():117473. PubMed ID: 32114007 [TBL] [Abstract][Full Text] [Related]
11. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials. Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935 [No Abstract] [Full Text] [Related]
12. Application of Individual qPCR Performance Parameters for Quality Control of Circulating MicroRNA Data. Brunet-Vega A; Quílez ME; Ramírez-Lázaro MJ; Lario S Methods Mol Biol; 2018; 1699():187-199. PubMed ID: 29086378 [TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Hamam R; Hamam D; Alsaleh KA; Kassem M; Zaher W; Alfayez M; Aldahmash A; Alajez NM Cell Death Dis; 2017 Sep; 8(9):e3045. PubMed ID: 28880270 [TBL] [Abstract][Full Text] [Related]
15. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer. Aboutalebi H; Bahrami A; Soleimani A; Saeedi N; Rahmani F; Khazaei M; Fiuji H; Shafiee M; Ferns GA; Avan A; Hassanian SM Int J Biochem Cell Biol; 2020 Jul; 124():105765. PubMed ID: 32428568 [TBL] [Abstract][Full Text] [Related]
16. Circulating miRNAs in nontumoral liver diseases. do Amaral AE; Cisilotto J; Creczynski-Pasa TB; de Lucca Schiavon L Pharmacol Res; 2018 Feb; 128():274-287. PubMed ID: 29037479 [TBL] [Abstract][Full Text] [Related]
17. A novel assay for exosomal and cell-free miRNA isolation and quantification. Grunt M; Failla AV; Stevic I; Hillebrand T; Schwarzenbach H RNA Biol; 2020 Apr; 17(4):425-440. PubMed ID: 31986967 [TBL] [Abstract][Full Text] [Related]
18. Circulating exosomal miRNAs: clinical significance in human cancers. Avgeris M; Panoutsopoulou K; Papadimitriou MA; Scorilas A Expert Rev Mol Diagn; 2019 Nov; 19(11):979-995. PubMed ID: 31594418 [No Abstract] [Full Text] [Related]
19. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma. Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613 [TBL] [Abstract][Full Text] [Related]
20. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer. Shi GL; Chen Y; Sun Y; Yin YJ; Song CX Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]